Asia Vital Components Co., Ltd. Logo

Asia Vital Components Co., Ltd.

3017.TW

(3.8)
Stock Price

648,00 TWD

8.49% ROA

30.04% ROE

35.67x PER

Market Cap.

235.735.650.000,00 TWD

68.09% DER

1.13% Yield

10.28% NPM

Asia Vital Components Co., Ltd. Stock Analysis

Asia Vital Components Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Asia Vital Components Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (27.92%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

4 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 Dividend Growth

With a history of consistent dividend increases over the last five years, the company has proven to be a reliable choice for investors seeking steady income.

6 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

7 ROA

The stock's ROA (7.44%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

8 DER

The stock has a reasonable amount of debt compared to its ownership (84%), suggesting a balanced financial position and a moderate level of risk.

9 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (5.982) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 PBV

The stock's high Price-to-Book Value (P/BV) ratio (6.45x) suggests it's overvalued, potentially making it an expensive investment.

11 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

Asia Vital Components Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Asia Vital Components Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Asia Vital Components Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Asia Vital Components Co., Ltd. Revenue
Year Revenue Growth
2006 14.564.366.000
2007 19.438.883.000 25.08%
2008 15.537.699.000 -25.11%
2009 15.108.512.000 -2.84%
2010 20.275.643.000 25.48%
2011 19.248.188.000 -5.34%
2012 17.855.049.000 -7.8%
2013 19.989.632.000 10.68%
2014 24.046.713.000 16.87%
2015 25.674.559.000 6.34%
2016 26.504.463.000 3.13%
2017 27.109.342.000 2.23%
2018 29.066.591.000 6.73%
2019 36.534.445.000 20.44%
2020 39.665.534.000 7.89%
2021 47.332.739.000 16.2%
2022 56.016.554.000 15.5%
2023 63.075.280.000 11.19%
2023 59.194.356.000 -6.56%
2024 65.935.420.000 10.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Asia Vital Components Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2006 395.365.000
2007 572.711.000 30.97%
2008 695.576.000 17.66%
2009 720.026.000 3.4%
2010 822.548.000 12.46%
2011 934.845.000 12.01%
2012 1.084.140.000 13.77%
2013 1.069.551.000 -1.36%
2014 1.313.872.000 18.6%
2015 1.179.174.000 -11.42%
2016 1.250.444.000 5.7%
2017 1.246.296.000 -0.33%
2018 1.589.088.000 21.57%
2019 1.938.036.000 18.01%
2020 1.929.062.000 -0.47%
2021 2.364.731.000 18.42%
2022 2.884.592.000 18.02%
2023 3.363.000.000 14.23%
2023 3.128.895.000 -7.48%
2024 3.719.348.000 15.88%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Asia Vital Components Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 675.843.000
2007 645.968.000 -4.62%
2008 500.965.000 -28.94%
2009 348.484.000 -43.76%
2010 325.389.000 -7.1%
2011 368.540.000 11.71%
2012 425.668.000 13.42%
2013 383.703.000 -10.94%
2014 435.390.000 11.87%
2015 438.093.000 0.62%
2016 434.622.000 -0.8%
2017 417.767.000 -4.03%
2018 521.162.000 19.84%
2019 469.101.000 -11.1%
2020 452.884.000 -3.58%
2021 553.628.000 18.2%
2022 756.575.000 26.82%
2023 829.956.000 8.84%
2023 802.959.000 -3.36%
2024 752.444.000 -6.71%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Asia Vital Components Co., Ltd. EBITDA
Year EBITDA Growth
2006 237.931.000
2007 1.387.331.000 82.85%
2008 1.165.471.000 -19.04%
2009 1.611.451.000 27.68%
2010 1.860.734.000 13.4%
2011 1.398.806.000 -33.02%
2012 792.050.000 -76.61%
2013 1.168.860.000 32.24%
2014 1.786.278.000 34.56%
2015 1.933.453.000 7.61%
2016 2.111.918.000 8.45%
2017 2.041.044.000 -3.47%
2018 2.037.735.000 -0.16%
2019 2.865.950.000 28.9%
2020 4.355.018.000 34.19%
2021 6.499.001.000 32.99%
2022 8.499.232.000 23.53%
2023 11.452.484.000 25.79%
2023 10.458.251.000 -9.51%
2024 12.078.216.000 13.41%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Asia Vital Components Co., Ltd. Gross Profit
Year Gross Profit Growth
2006 1.913.075.000
2007 2.921.060.000 34.51%
2008 2.296.482.000 -27.2%
2009 2.620.166.000 12.35%
2010 3.239.100.000 19.11%
2011 2.584.299.000 -25.34%
2012 2.160.572.000 -19.61%
2013 2.375.707.000 9.06%
2014 2.929.809.000 18.91%
2015 3.235.328.000 9.44%
2016 3.695.049.000 12.44%
2017 3.331.212.000 -10.92%
2018 3.447.278.000 3.37%
2019 4.314.299.000 20.1%
2020 6.231.723.000 30.77%
2021 8.385.681.000 25.69%
2022 10.849.617.000 22.71%
2023 13.662.092.000 20.59%
2023 12.388.120.000 -10.28%
2024 14.725.896.000 15.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Asia Vital Components Co., Ltd. Net Profit
Year Net Profit Growth
2006 -333.094.000
2007 553.378.000 160.19%
2008 466.311.000 -18.67%
2009 782.497.000 40.41%
2010 1.020.762.000 23.34%
2011 665.783.000 -53.32%
2012 33.878.000 -1865.24%
2013 245.920.000 86.22%
2014 728.997.000 66.27%
2015 741.353.000 1.67%
2016 860.131.000 13.81%
2017 886.681.000 2.99%
2018 711.261.000 -24.66%
2019 957.969.000 25.75%
2020 1.915.846.000 50%
2021 2.900.627.000 33.95%
2022 4.162.261.000 30.31%
2023 5.703.648.000 27.02%
2023 5.304.713.000 -7.52%
2024 7.789.020.000 31.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Asia Vital Components Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 -1
2007 2 200%
2008 1 0%
2009 2 50%
2010 4 33.33%
2011 2 -200%
2012 0 0%
2013 1 0%
2014 2 100%
2015 2 0%
2016 2 0%
2017 2 0%
2018 2 -100%
2019 3 50%
2020 5 60%
2021 8 37.5%
2022 12 27.27%
2023 15 21.43%
2023 14 0%
2024 20 30%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Asia Vital Components Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2006 237.869.000
2007 1.231.560.000 80.69%
2008 162.996.000 -655.58%
2009 1.296.988.000 87.43%
2010 676.148.000 -91.82%
2011 77.654.000 -770.72%
2012 295.818.000 73.75%
2013 445.684.000 33.63%
2014 590.802.000 24.56%
2015 1.041.732.000 43.29%
2016 217.509.000 -378.94%
2017 805.545.000 73%
2018 -723.344.000 211.36%
2019 756.450.000 195.62%
2020 2.404.133.000 68.54%
2021 1.213.332.000 -98.14%
2022 4.941.943.000 75.45%
2023 6.556.267.000 24.62%
2023 3.205.975.000 -104.5%
2024 1.331.718.000 -140.74%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Asia Vital Components Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2006 1.112.741.000
2007 1.882.363.000 40.89%
2008 1.250.907.000 -50.48%
2009 2.026.166.000 38.26%
2010 1.331.168.000 -52.21%
2011 1.248.833.000 -6.59%
2012 1.372.225.000 8.99%
2013 1.373.398.000 0.09%
2014 1.961.757.000 29.99%
2015 2.493.157.000 21.31%
2016 2.153.706.000 -15.76%
2017 1.806.031.000 -19.25%
2018 971.341.000 -85.93%
2019 2.457.835.000 60.48%
2020 4.869.582.000 49.53%
2021 2.841.259.000 -71.39%
2022 8.840.001.000 67.86%
2023 10.324.207.000 14.38%
2023 3.785.815.000 -172.71%
2024 2.462.668.000 -53.73%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Asia Vital Components Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2006 874.872.000
2007 650.803.000 -34.43%
2008 1.087.911.000 40.18%
2009 729.178.000 -49.2%
2010 655.020.000 -11.32%
2011 1.171.179.000 44.07%
2012 1.076.407.000 -8.8%
2013 927.714.000 -16.03%
2014 1.370.955.000 32.33%
2015 1.451.425.000 5.54%
2016 1.936.197.000 25.04%
2017 1.000.486.000 -93.53%
2018 1.694.685.000 40.96%
2019 1.701.385.000 0.39%
2020 2.465.449.000 30.99%
2021 1.627.927.000 -51.45%
2022 3.898.058.000 58.24%
2023 3.767.940.000 -3.45%
2023 579.840.000 -549.82%
2024 1.130.950.000 48.73%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Asia Vital Components Co., Ltd. Equity
Year Equity Growth
2006 4.395.632.000
2007 4.719.493.000 6.86%
2008 4.898.572.000 3.66%
2009 5.517.779.000 11.22%
2010 5.715.122.000 3.45%
2011 7.256.421.000 21.24%
2012 7.006.666.000 -3.56%
2013 7.417.805.000 5.54%
2014 8.482.352.000 12.55%
2015 8.739.447.000 2.94%
2016 8.605.673.000 -1.55%
2017 8.826.684.000 2.5%
2018 9.008.570.000 2.02%
2019 9.333.910.000 3.49%
2020 11.288.338.000 17.31%
2021 14.084.926.000 19.86%
2022 17.423.084.000 19.16%
2023 22.648.240.000 23.07%
2023 25.847.078.000 12.38%
2024 27.869.322.000 7.26%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Asia Vital Components Co., Ltd. Assets
Year Assets Growth
2006 13.607.778.000
2007 12.478.394.000 -9.05%
2008 11.765.616.000 -6.06%
2009 12.491.111.000 5.81%
2010 14.801.774.000 15.61%
2011 16.071.034.000 7.9%
2012 16.939.080.000 5.12%
2013 21.896.405.000 22.64%
2014 23.602.555.000 7.23%
2015 26.974.870.000 12.5%
2016 27.623.043.000 2.35%
2017 28.214.076.000 2.09%
2018 30.396.264.000 7.18%
2019 35.558.727.000 14.52%
2020 40.676.236.000 12.58%
2021 50.865.107.000 20.03%
2022 60.473.948.000 15.89%
2023 66.152.598.000 8.58%
2023 71.667.217.000 7.69%
2024 77.999.094.000 8.12%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Asia Vital Components Co., Ltd. Liabilities
Year Liabilities Growth
2006 9.212.146.000
2007 7.758.901.000 -18.73%
2008 6.867.044.000 -12.99%
2009 6.973.332.000 1.52%
2010 9.086.652.000 23.26%
2011 8.814.613.000 -3.09%
2012 9.932.414.000 11.25%
2013 14.478.600.000 31.4%
2014 15.120.203.000 4.24%
2015 18.235.423.000 17.08%
2016 19.017.370.000 4.11%
2017 19.387.392.000 1.91%
2018 21.387.694.000 9.35%
2019 26.224.817.000 18.44%
2020 29.387.898.000 10.76%
2021 36.780.181.000 20.1%
2022 43.050.864.000 14.57%
2023 43.504.358.000 1.04%
2023 45.820.139.000 5.05%
2024 49.459.575.000 7.36%

Asia Vital Components Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
167.7
Net Income per Share
17.24
Price to Earning Ratio
35.67x
Price To Sales Ratio
3.67x
POCF Ratio
17.83
PFCF Ratio
25.23
Price to Book Ratio
9.86
EV to Sales
3.44
EV Over EBITDA
19.24
EV to Operating CashFlow
16.74
EV to FreeCashFlow
23.7
Earnings Yield
0.03
FreeCashFlow Yield
0.04
Market Cap
235,74 Bil.
Enterprise Value
221,40 Bil.
Graham Number
155.53
Graham NetNet
-4.11

Income Statement Metrics

Net Income per Share
17.24
Income Quality
1.61
ROE
0.3
Return On Assets
0.08
Return On Capital Employed
0.25
Net Income per EBT
0.67
EBT Per Ebit
1.06
Ebit per Revenue
0.14
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.05
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.22
Operating Profit Margin
0.14
Pretax Profit Margin
0.15
Net Profit Margin
0.1

Dividends

Dividend Yield
0.01
Dividend Yield %
1.13
Payout Ratio
0.29
Dividend Per Share
6.96

Operating Metrics

Operating Cashflow per Share
34.5
Free CashFlow per Share
24.38
Capex to Operating CashFlow
0.29
Capex to Revenue
0.06
Capex to Depreciation
1.77
Return on Invested Capital
0.17
Return on Tangible Assets
0.08
Days Sales Outstanding
27.81
Days Payables Outstanding
113.34
Days of Inventory on Hand
156.14
Receivables Turnover
13.12
Payables Turnover
3.22
Inventory Turnover
2.34
Capex per Share
10.12

Balance Sheet

Cash per Share
87,28
Book Value per Share
74,46
Tangible Book Value per Share
74.02
Shareholders Equity per Share
62.37
Interest Debt per Share
43.56
Debt to Equity
0.68
Debt to Assets
0.21
Net Debt to EBITDA
-1.25
Current Ratio
1.45
Tangible Asset Value
28,37 Bil.
Net Current Asset Value
9,50 Bil.
Invested Capital
34353550000
Working Capital
18,40 Bil.
Intangibles to Total Assets
0
Average Receivables
5,51 Bil.
Average Payables
15,22 Bil.
Average Inventory
20015601500
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Asia Vital Components Co., Ltd. Dividends
Year Dividends Growth
2003 2
2004 0 0%
2005 0 0%
2008 1 0%
2009 0 0%
2010 2 100%
2011 1 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1 100%
2016 1 0%
2017 1 0%
2018 1 100%
2019 1 0%
2020 1 0%
2021 3 50%
2022 4 50%
2023 5 0%
2024 7 33.33%

Asia Vital Components Co., Ltd. Profile

About Asia Vital Components Co., Ltd.

Asia Vital Components Co., Ltd. provides thermal solutions worldwide. The company offers DC, EC, and thin centrifugal fans; and fan arrays, far-end radiators, radiators, compressor radiators, heat sinks, and heat pipes/vapor chambers. It also designs and manufactures PC related casing systems. In addition, it offers camera modules, hinges, and touch panel products. Further, it manufactures motherboards; and provides system assembly and machine cooling programs. The company's products are used in various areas, including computers, communication equipment, energy, cars, transportation, and other fields of industrial cooling. Asia Vital Components Co., Ltd. was incorporated in 1991 and is headquartered in New Taipei City, Taiwan.

CEO
Mr. Ching-Hang Shen
Employee
11.131
Address
No. 24, Wuquan 2nd Road
New Taipei City, 242

Asia Vital Components Co., Ltd. Executives & BODs

Asia Vital Components Co., Ltd. Executives & BODs
# Name Age
1 Mr. Ching-Hang Shen
Chairman, President, Chief Executive Officer & GM
70
2 Mr. Yi Cheng Chen
Vice President & Chief Financial Officer
70
3 Ms. Shu Hua Lin
Chief Accounting Officer
70
4 Yi Fen Li
Director of Human Resource Division
70
5 Mr. Yi-Chen Chen
Vice President & Director
70
6 Mr. Chiu-Mao Huang
Vice President & Director
70
7 Mr. Jui Pin Wang
Vice President & Director
70
8 Shu Mei Chen
Head of Corporate Quality Division
70
9 Ms. Hui-Ying Kuo
Company Secretary
70

Asia Vital Components Co., Ltd. Competitors